Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

THE EFFECT OF SU-JOK THERAPY APPLIED TO INTENSİVE CARE PATIENTS UNDER MECHANICVENTILATION SUPPORT

2. juni 2026 oppdatert av: MELTEM KALAYCI, Hasan Kalyoncu University

THE EFFECT OF SU-JOK THERAPY APPLIED TO INTENSIVE CARE PATIENTS UNDER MECHANICAL VENTILATION SUPPORT ON PAIN AND PHYSIOLOGICAL PARAMETERS.

The aim of this study is to examine the effect of Su Jok Therapy, applied to patients receiving mechanical ventilation support in the intensive care unit, on pain and physiological parameters.

Studieoversikt

Detaljert beskrivelse

Mechanical ventilation (MV), one of the most common treatment methods in Intensive Care Units (ICUs), is a critical treatment approach to ensure adequate respiratory function in patients.

Although mechanical ventilation is a life-saving treatment method in ICUs, it can cause many physiological and psychological problems for patients. Furthermore, excessive exposure to physical, psychosocial, and environmental stressors can affect the patient's autonomic response and vital parameters (tachycardia, hypertension, tachypnea), leading to hemodynamic instability

The World Health Organization (WHO) defines Integrated, Complementary, and Alternative Medicine Practices as the provision of healthcare services that are not part of a country's own tradition or conventional medicine and are not fully integrated into the dominant healthcare system In intensive care patients, non-pharmacological methods such as aromatherapy, music therapy, massage, reflexology, acupressure, and Reiki are used as complementary and alternative treatments. Su Jok, one of these non-pharmacological methods, is an alternative treatment method based on traditional Korean medicine. Su Jok is a treatment method that uses the feet and hands, derived from the Korean words Su (hand) and Jok (foot). In the literature, it is argued that nurses can apply Su Jok therapy as an integrative method in symptom management due to its simplicity of application, lack of side effects, and non-invasiveness, which is similar to the philosophy of integrative nursing. Looking at the literature, very few studies on Su Jok therapy have been found. No studies have been found in the literature regarding the effect of Su Jok therapy on intensive care patients and patients on mechanical ventilation support.

Studietype

Intervensjonell

Registrering (Faktiske)

30

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Kahramanmaraş
      • Kahramanmaraş, Kahramanmaraş, Tyrkia (Türkiye), 46050
        • Kahramanmaraş

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Patients who are in intensive care,

    • Patients receiving IMV support,
    • Patients who were admitted to the ICU from the start date of the study and are planned to be monitored for at least 24 hours,
    • Patients without any problems in the area where Su-Jok will be applied,
    • Patients with GCS > 3, RASS between +1 and +4, BPS > 3

Exclusion Criteria:

  • • Patients in the ward,

    • Patients with any problems such as fungal infections or wounds in the area where Su Jok will be applied,
    • Patients with a GCS of 3,
    • Patients not receiving IMV support will not be included in the study.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Ingen inngripen: Kontrollgruppe
Ingen intervensjon vil bli brukt på kontrollgruppen.
Eksperimentell: Intervetion group
In the intervention group, su-jok seed therapy will be applied to the su-jok reflection zones on the hands.
In the intervention group, the reflex zones on the hands were identified with a probe. Buckwheat seeds were fixed to these areas with adhesive tape and massaged. The seeds remained in place for 4 hours. After 2 hours, these areas were stimulated with a 1-2 minute massage. Measurements were recorded on a data collection form. The application was carried out for 3 days.
Placebo komparator: Placebo group
In the placebo group, su-jok seed therapy will be applied to areas on the hands that are different from the reflection zones.
In the placebo group, reflex zones on the hand were identified using a probe. Buckwheat seeds were fixed to a different area near these zones with a seed patch and massaged. The seeds remained in place for 4 hours. After 2 hours, these areas were stimulated with a 1-2 minute massage. Measurements were recorded on a data collection form. The application was carried out for 3 days.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Systolic Blood Pressure
Tidsramme: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Hemodynamic response measured by systolic blood pressure
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Heart Rate (Pulse Rate)
Tidsramme: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Heart rate measured in beats per minute
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Oxygen Saturation (SpO₂)
Tidsramme: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Peripheral oxygen saturation
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Body Temperature
Tidsramme: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Core body temperature
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Respiratory Rate
Tidsramme: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Number of breaths per minute
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Richmond Agitation-Sedation Scale (RASS)
Tidsramme: baseline, 1 hour, 4 hours after intervention
Negative scores indicate sedation, positive scores indicate agitation
baseline, 1 hour, 4 hours after intervention
Behavioral Pain Scale (BPS)
Tidsramme: baseline, 1 hour, 4 hours after intervention
Higher scores indicate more severe pain
baseline, 1 hour, 4 hours after intervention

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Hemodynamic Stability Index (Systolic/Diastolic Blood Pressure Change)
Tidsramme: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Change in systolic and diastolic blood pressure from baseline to post-intervention measurements.
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Oxygenation Trend (SpO₂ Change Over Time)
Tidsramme: baseline, 15 minutes, 60 minutes, 4 hours after intervention
hanges in peripheral oxygen saturation over the intervention period.
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Heart Rate Variability (Clinical Pulse Trend)
Tidsramme: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Changes in heart rate measured in beats per minute during and after intervention.
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Sedation-Agitation Level Stability (RASS Trend)
Tidsramme: baseline, 1 hour, 4 hours after intervention
Changes in Richmond Agitation-Sedation Scale (RASS) scores over time indicating sedation or agitation level.
baseline, 1 hour, 4 hours after intervention
Pain Intensity Change (Behavioral Pain Scale Trend)
Tidsramme: baseline, 1 hour, 4 hours after intervention
Changes in Behavioral Pain Scale (BPS) scores indicating pain severity over time.
baseline, 1 hour, 4 hours after intervention
Respiratory Stability (Respiratory Rate Change)
Tidsramme: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Changes in respiratory rate indicating respiratory stability during intervention.
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Temperature Stability
Tidsramme: baseline, 15 minutes, 60 minutes, 4 hours after intervention
hanges in body temperature over time following intervention.
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Non-pharmacological Intervention Effectiveness (Overall Clinical Stability Score)
Tidsramme: baseline, 4 hours after intervention
Composite assessment of physiological stability based on vital signs and sedation/pain scores.
baseline, 4 hours after intervention

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Studiestol: NERMİN OLGUN, Prof. Dr., Hasan Kalyoncu University
  • Hovedetterforsker: MELTEM KALAYCI, Hasan Kalyoncu University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. mars 2025

Primær fullføring (Faktiske)

1. mars 2025

Studiet fullført (Faktiske)

1. november 2025

Datoer for studieregistrering

Først innsendt

30. desember 2025

Først innsendt som oppfylte QC-kriteriene

2. juni 2026

Først lagt ut (Faktiske)

8. juni 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

8. juni 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

2. juni 2026

Sist bekreftet

1. juni 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere